AAVrh10-PCCA Gene Therapy Trial for Propionic Acidemia Initiated
A clinical trial is underway to assess the safety and efficacy of AAVrh10-PCCA gene therapy for propionic acidemia.
Asset / Drug
Drug and asset intelligence for Propionic Acidemia with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
Gene Therapy
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.